Term Name: EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor
Synonyms: (5Z,13E)-(15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dienoate:NADP(+) 9-oxidoreductase inhibitor, (5Z,13E)-(15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dienoate:NADP(+) 9-oxidoreductase inhibitors, 9-keto-prostaglandin E2 reductase inhibitor, 9-keto-prostaglandin E2 reductase inhibitors, 9-ketoprostaglandin reductase inhibitor, 9-ketoprostaglandin reductase inhibitors, EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitors, EC 1.1.1.189 inhibitor, EC 1.1.1.189 inhibitors, PGE-9-ketoreductase inhibitor, PGE-9-ketoreductase inhibitors, PGE2 9-oxoreductase inhibitor, PGE2 9-oxoreductase inhibitors, PGE2-9-ketoreductase inhibitor, PGE2-9-ketoreductase inhibitors, PGE2-9-OR inhibitor, PGE2-9-OR inhibitors, prostaglandin 9-ketoreductase inhibitor, prostaglandin 9-ketoreductase inhibitors, prostaglandin E 9-ketoreductase inhibitor, prostaglandin E 9-ketoreductase inhibitors, prostaglandin E2-9-oxoreductase inhibitor, prostaglandin E2-9-oxoreductase inhibitors, prostaglandin-E2 9-reductase (EC 1.1.1.189) inhibitor, prostaglandin-E2 9-reductase (EC 1.1.1.189) inhibitors, reductase, 15-hydroxy-9-oxoprostaglandin inhibitor, reductase, 15-hydroxy-9-oxoprostaglandin inhibitors
Definition: An EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor that interferes with the action of prostaglandin-E2 9-reductase (EC 1.1.1.189).
Ontology: ChEBI [CHEBI:77119]  ( EBI )

Relationships
is a type of: EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor
inverse has_role: hexadecanoic acid